ArticleJournal for immunotherapy of cancer2020

CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells.

Anne W J Martens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.